{"id":307470,"date":"2024-02-22T12:38:25","date_gmt":"2024-02-22T18:38:25","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=307470"},"modified":"2024-02-22T10:52:20","modified_gmt":"2024-02-22T16:52:20","slug":"supreme-court-three-states-plaintiffs-abortion-pill","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/supreme-court-three-states-plaintiffs-abortion-pill\/","title":{"rendered":"Supreme Court tells three states they won’t be plaintiffs in abortion pill case"},"content":{"rendered":"
<\/div>

The U.S. Supreme Court has denied the states of Idaho, Kansas, and Missouri from intervening in an upcoming abortion pill lawsuit. The Court will soon begin hearing arguments<\/a>.<\/p>\n

Plaintiffs in the case Alliance for Hippocratic Medicine (AHM) v. Food and Drug Administration (FDA)<\/em> are seeking to hold the Food and Drug Administration (FDA) accountable for removing the safety standards it originally deemed necessary to ensure the health and safety of women and girls using mifepristone, a chemical abortion drug.<\/p>\n

Abortion Pill Approval and Conflicts<\/strong><\/p>\n

The abortion pill mifepristone was\u00a0approved<\/a> by the FDA in 2000, to be prescribed in-person through the 7th week of pregnancy.\u00a0 In\u00a02016<\/a>, the FDA\u00a0removed requirements<\/a> that all non-fatal adverse events be reported, allowed the pill to be prescribed through the 10th week of pregnancy, removed the requirement that only physicians prescribe the drug, and no longer required women to take the first pill at the facility.<\/p>\n

In 2021, the Biden FDA eliminated the in-person dispensing requirement<\/a>\u00a0and enabled the abortion pill to be permanently\u00a0shipped by mail<\/a>. Then in 2023, the FDA further expanded access to allow retail pharmacies to dispense the drug<\/a>.<\/p>\n

Today, profiteers of the deadly abortion pill regimen are flouting the FDA\u2019s REMS safety regulations on the abortion pill. They prescribe<\/a> the pill past<\/a> FDA gestational limits, may not have the ability to properly rule out<\/a> potentially deadly ectopic pregnancies as required, prescribe ‘advanced provision<\/a>‘ abortion pills to women who are not even pregnant<\/a>, allow pharmacists to prescribe<\/a> the drug, and encourage women to lie<\/a> about abortion pill complications by claiming they are experiencing a natural miscarriage.<\/p>\n

Live Action News previously<\/a> documented potential\u00a0conflicts of interest<\/a> and an incestuous funding trail<\/a> from the investors in U.S. abortion pill manufacturers Danco Laboratories and\u00a0GenBioPro<\/a>, whose own dollars have been funneled to various groups behind clinical trials and studies of the abortion pill and its purported safety and effectiveness.<\/p>\n

In some instances, the studies have been authored<\/a> by people on the payroll<\/a> of the abortion pill’s manufacturers<\/em>.<\/p>\n

Lawsuit and Background<\/strong><\/p>\n

AHM’s lawsuit was initiated<\/a> in November of 2022 by a group of medical doctors and organizations who claimed the 2000 approval of the abortion pill mifepristone was illegal and the expanded use of the abortion pill was unsafe<\/a>. The doctors testified<\/a>\u00a0to treating women with severe complications \u2014 \u201cmany who presented to the emergency room.\u201d<\/p>\n

On April 7, 2023, U.S. District Court Judge Matthew J. Kacsmaryk\u00a0ruled<\/a> in favor of the plaintiffs to immediately suspend the 2000 approval and subsequent FDA changes to the abortion pill. But the case was appealed to the U.S. Court of Appeals for the Fifth Circuit, which issued a partial stay.<\/p>\n

After the Biden Administration opposed the lower court decision, AHM\u2019s case\u00a0went back<\/a>\u00a0to the Fifth Circuit which\u00a0heard oral arguments<\/a>\u00a0in May. A\u00a062-page decision<\/a> issued August 16, 2023, by the appeals court ruled<\/a>\u00a0to allow mifepristone to remain \u201cavailable to the public under the conditions for use that\u00a0existed<\/a>\u201d\u00a0prior to 2016<\/em>.<\/p>\n